First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis (Q39645010)
Jump to navigation
Jump to search
scientific article published on November 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis |
scientific article published on November 2010 |
Statements
1 reference
First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis (English)
1 reference
Benoît Laleu
1 reference
Francesca Gaggini
1 reference
Mike Orchard
1 reference
Laetitia Fioraso-Cartier
1 reference
Laurène Cagnon
1 reference
Sophie Houngninou-Molango
1 reference
Angelo Gradia
1 reference
Guillaume Duboux
1 reference
Cédric Merlot
1 reference
Freddy Heitz
1 reference
Cédric Szyndralewiez
1 reference
Patrick Page
1 reference
1 November 2010
1 reference
1 reference
7715-7730
1 reference
Identifiers
1 reference